Cure8 research brief
Entamoeba histolytica infection can mimic IBD flare symptoms and may be made worse by steroids or immunosuppressants. Identifying amoebiasis with stool testing can change treatment decisions and prevent harm.
Clinicians treating IBD patients (particularly in endemic regions), adult IBD patients preparing for steroid or immunosuppressive therapy, and caregivers of patients with recent travel or residence in high-prevalence areas.
This retrospective laboratory study reviewed stool parasitological examinations (SPE) submitted from a gastroenterology service between 2016–2025. Among 249 SPEs from patients with IBD, 67 (27%) were positive for the E. histolytica/E. dispar complex.
Findings included both trophozoite (vegetative) and cystic forms, and many samples also contained nonpathogenic intestinal parasites. The authors emphasize performing SPE as part of the differential diagnosis for suspected IBD flare-ups, especially in endemic areas and prior to immunosuppression.
Practical takeaway If you have IBD and live in or have traveled to regions where amoebiasis is common, clinicians should consider stool parasite testing when symptoms suggest a flare before escalating immunosuppression. This study supports incorporating SPE into diagnostic workflows for IBD patients with compatible symptoms in endemic settings.
This is a retrospective laboratory-based study from a single center covering 2016–2025; prevalence and positivity rates will vary by region and referral patterns. The report is based on SPE results and emphasizes diagnostic vigilance rather than testing a new intervention.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study suggests Aeromonas species are more frequently detected and at higher abundance in people with IBD versus non-IBD patients, and are associated with inflammatory markers — a finding that could point to a...
Aeromonas species were detected more frequently in people with IBD than in patients without IBD and were linked to higher inflammatory markers—so clinicians and patients may see Aeromonas on stool PCR more often in the...
Wearable-derived digital biomarkers could enable earlier, less burdensome detection of IBD flares and better remote monitoring if they reliably predict mucosal inflammation.
